Mercer Global Advisors Inc Abiomed Inc Transaction History

Mercer Global Advisors Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$242.49 - $301.46 $13,579 - $16,881	56 Added 2.94%	1,962 $482,000
Q2 2022 Aug 10, 2022	BUY	$224.73 - $338.64 $135,512 - $204,199	603 Added 46.28%	1,906 $472,000
Q1 2022 May 10, 2022	BUY	$277.25 - $366.29 $1,386 - $1,831	5 Added 0.39%	1,303 $432,000
Q4 2021 Feb 04, 2022	BUY	$300.63 - $371.35 $12,626 - $15,596	42 Added 3.34%	1,298 $466,000
Q3 2021 Nov 10, 2021	SELL	$310.19 - $376.2 $12,717 - $15,424	-41 Reduced 3.16%	1,256 $409,000
Q2 2021 Aug 10, 2021	BUY	$262.71 - $351.17 $18,389 - $24,581	70 Added 5.7%	1,297 $405,000
Q1 2021 May 11, 2021	BUY	$285.92 - $355.13 $101,787 - $126,426	356 Added 40.87%	1,227 $391,000
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $12,594 - $16,210	50 Added 6.09%	871 $282,000
Q3 2020 Dec 10, 2020	BUY	$255.22 - $317.0 $209,535 - $260,257	821 New	821 $227,000
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $218,335 - $247,897	-870 Closed	0 $0
Q1 2019 Apr 23, 2019	SELL	$276.39 - $362.25 $3.51 Million - $4.59 Million	-12,684 Reduced 93.58%	870 $248,000
Q1 2019 Apr 12, 2019	BUY	$276.39 - $362.25 $3.75 Million - $4.91 Million	13,554 New	13,554 $4.41 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.